Observational studyJournal of cardiothoracic surgery2026
Post-LVAD diuretic trajectories and predictors of diuretic resistance.
Observational study in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRenal dysfunction and diuretic resistance may persist or develop after left ventricular assist device (LVAD) implantation despite restoration of cardiac output (CO). This study aimed to characterize post-LVAD diuretic trajectories and identify hemodynamic predictors of diuretic resistance or diuretic de-escalation in patients receiving ≤ 160 mg versus > 160 mg of furosemide prior to implantation.
methodsIn this retrospective, single-center observational study, 39 patients with advanced heart failure (79.5% male; median age 58 [53; 64] years) who underwent implantation of a HeartMate 3 LVAD as a bridge to transplantation between December 2017 and March 2024 were included. Pre-implant clinical, laboratory, echocardiographic, and invasive hemodynamic parameters were analysed according to baseline diuretic dose and subsequent changes in diuretic requirements following LVAD implantation.
resultsPatients receiving > 160 mg/day of furosemide (31%) had significantly higher right atrial pressure (p = 0.006), higher mean pulmonary artery pressure (p = 0.028), and lower pulmonary artery pulsatility index (PAPi; p = 0.004) compared with those receiving ≤ 160 mg/day. Among low-dose patients, 33% developed post-LVAD diuretic resistance, associated with lower PAPi and higher CO. In multivariate analysis, lower PAPi independently predicted diuretic resistance (OR 0.82, 95% CI 0.69-0.98; p = 0.027), while higher CO was also associated with increased risk (OR 3.09, 95% CI 1.25-7.59; p = 0.014). PAPi demonstrated significant inverse discrimination for diuretic resistance (AUC 0.26; p = 0.005). Kaplan-Meier analysis showed reduced event-free survival in patients with PAPi ≤ 1.85 (log-rank p = 0.022).
conclusionDespite normalization of CO after LVAD implantation, diuretic resistance may persist or emerge in the setting of right ventricular - pulmonary uncoupling. Low pre-implant PAPi and venous congestion appear central to impaired renal response, highlighting the importance of comprehensive right-sided hemodynamic assessment during LVAD candidate evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.